2013
DOI: 10.1152/ajpendo.00405.2013
|View full text |Cite
|
Sign up to set email alerts
|

Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet

Abstract: Conover CA, Harstad SL, Tchkonia T, Kirkland JL. Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet. Am J Physiol Endocrinol Metab 305: E1145-E1153, 2013. First published September 17, 2013 doi:10.1152/ajpendo.00405.2013.-Accumulation of visceral fat, more so than subcutaneous fat, is strongly associated with severe metabolic complications. However, the factors regulating depot-specific adipogenesis are poorly understood. In this study, we show di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
36
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 30 publications
(41 citation statements)
references
References 35 publications
(44 reference statements)
4
36
1
Order By: Relevance
“…It was also noted that PAPP-A was highly expressed in human preadipocytes obtained from visceral fat depots compared to those from subcutaneous fat depots (9). Similar findings were reported for mice (10). These studies suggest not only diagnostic and prognostic value, but also potential therapeutic value for PAPP-A.…”
Section: Introductionsupporting
confidence: 90%
“…It was also noted that PAPP-A was highly expressed in human preadipocytes obtained from visceral fat depots compared to those from subcutaneous fat depots (9). Similar findings were reported for mice (10). These studies suggest not only diagnostic and prognostic value, but also potential therapeutic value for PAPP-A.…”
Section: Introductionsupporting
confidence: 90%
“…Thus, reduction in PAPP-A expression may be another mechanism responsible for resveratrol’s beneficial effects. Further evaluation of the specific role of PAPP-A in depot-specific adipogenesis is needed, as these findings in human preadipocytes in conjunction with the work in mice (Conover et al 2013) suggest the potential for PAPP-A to be a therapeutic target in the treatment of visceral obesity.…”
Section: Resultsmentioning
confidence: 99%
“…This is similar to a model proposed for PAPP-A in atherosclerotic plaque progression (Conover 2010). A recent study in mice suggests a novel interactive in vivo setting whereby PAPP-A regulates visceral adipose tissue response to insulin (Conover et al , 2013). …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Like IGF-I, PAPP-A displays antagonistic pleiotropy [2], i.e., expression is important early in life for optimal fetal growth and reproductive function but is associated in the adult with aging and age-related diseases [3,4]. We have shown that mice deficient in PAPP-A are resistant to the development of experimentally-induced atherosclerosis, diabetic nephropathy, and visceral obesity [46]. Moreover, these PAPP-A knock-out (KO) mice live 30–40% longer than their wild-type (WT) littermates with delayed occurrence of spontaneous cancers and reduced incidence and severity of many degenerative diseases of age [7].…”
Section: Introductionmentioning
confidence: 99%